Collaborate Disseminate
A new review article published in the journal Trends in Cancer is presenting a promising case for phenformin, an old diabetes drug related to metformin, being repurposed as an adjunct to new immunotherapy cancer treatments. A phase 1 clinical trial is … Continue reading Old diabetes drug given new life as potential cancer treatment
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the prima… Continue reading First head-to-head trial pits psychedelic therapy against antidepressant
Following an influential analysis published in February, a team of Stanford University researchers has conducted the first large survey into the very modern phenomenon of “Zoom Fatigue.” The new study reveals women suffer from greater exhaustion follow… Continue reading New Stanford “Zoom Fatigue” study finds women affected more than men
New research from a team of Dutch scientists is offering novel insights into the relationship between diet, gut bacteria, and intestinal inflammation. The study, tracking nearly 1,500 people, found consistent associations between pro-inflammatory bacte… Continue reading Study links poor diet to pro-inflammatory gut bacteria
The winners of the 7th Fine Art Photography Awards present a surreal assortment of shots from sci-fi styled snaps of subways to spectacularly sublime landscapes. We’ve handpicked our highlights from this year’s massive collection of celebrated images.C… Continue reading Spectacular sights in the 7th Fine Art Photography Awards
How long is a person’s ability to safely drive impaired after consuming cannabis? A world-first meta-analysis looking at 80 different studies suggests cannabis intoxication spans anywhere from three to 10 hours, raising questions over some roadside tes… Continue reading Study calculates duration of driving impairment after smoking cannabis
The neurodegeneration associated with Alzheimer’s disease can often take 10 or 20 years before clinical signs of cognitive decline become apparent. Identifying these early preclinical stages of Alzheimer’s is still very much a challenge to researchers. One hypothesis, slowly building an intriguing body of evidence, suggests periodontal disease could be an early causal contributor to Alzheimer’s neurodegeneration.
Category: Health & Wellbeing, Lifestyle
Tags: Alzheimer’s Disease, Dementia, Brain, Mouth-care, Bacteria, Microbiome, Neuroscience
Continue reading New evidence links harmful oral bacteria with early Alzheimer’s signs
Researchers from the Indiana University School of Medicine are one step closer to an objective clinical blood test for mood disorders. A robust new study is describing the development of a panel of blood-based biomarkers that can distinguish between de… Continue reading Blood test for depression & bipolar disorder one step closer to reality
More than one in 10 adults in the United States suffer from chronic rhinosinusitis, a persistent inflammatory sinus condition. A new brain imaging study is suggesting chronic rhinosinusitis is associated with functional brain connectivity changes that … Continue reading Chronic sinus inflammation linked to altered brain activity
A striking new study testing a number of over-the-counter weight loss and sports supplements has found they contain many combinations of stimulants that have either previously been prohibited by the FDA or never approved for human consumption.Continue … Continue reading Experimental stimulants common in weight loss and sport supplements